about
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitisOral 5-aminosalicylic acid for induction of remission in ulcerative colitisOral 5-aminosalicylic acid for induction of remission in ulcerative colitisOral 5-aminosalicylic acid for maintenance of remission in ulcerative colitisOral 5-aminosalicylic acid for maintenance of remission in ulcerative colitisOral 5-aminosalicylic acid for induction of remission in ulcerative colitisOral 5-aminosalicylic acid for induction of remission in ulcerative colitisA controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin).How to do without steroids in inflammatory bowel disease.Medical treatment of inflammatory bowel disease: new therapies, new drugs.'Conversion' from ulcerative colitis to Crohn's disease associated with corticosteroid treatment.Segmental variability of glucocorticoid induced electrolyte transport in rat colon.Drug therapy of ulcerative colitisNa+-K+-activated adenosine triphosphatase and intestinal electrolyte transport. Effect of adrenal steroids.Effect of glucocorticoids on rectal transport in normal subjects and patients with ulcerative colitisDecrease of reactive-oxygen-producing granulocytes and release of IL-10 into the peripheral blood following leukocytapheresis in patients with active ulcerative colitis.Relationship Between Cytomegalovirus Infection and Steroid Resistance in Inflammatory Bowel Disease: A Meta-AnalysisIntestinal epithelium-specific knockout of the cytochrome P450 reductase gene exacerbates dextran sulfate sodium-induced colitisThe predictive variable regarding relapse in patients with ulcerative colitis after achieving endoscopic mucosal healing.The controlled trialFactors in the pathogenesis of peptic ulcer. The present basis of treatmentMicrobes, intestinal inflammation and probiotics.Clinical trials in ulcerative colitis: a historical perspective.The long journey of salicylates in ulcerative colitis: The past and the future.Vedolizumab for the treatment of ulcerative colitis.Budesonide for the treatment of ulcerative colitis.Medical treatment of ulcerative colitis.Effect of aging on healthcare costs of inflammatory bowel disease: a glimpse into the future.The medical treatment of ulcerative colitis.Drug therapy of inflammatory bowel disease.A controlled comparison of corticotropin and hydrocortisone in the treatment of severe proctocolitis.Glucocorticoid receptors are down-regulated in inflamed colonic mucosa but not in peripheral blood mononuclear cells from patients with inflammatory bowel disease.The problem of chronic inflammatory bowel disease.Myasthenia gravis, ulcerative colitis and lichen planus.Ulcerative colitis: an overview.Granulocyte, monocyte/macrophage apheresis for inflammatory bowel disease: the first 100 patients treated in Scandinavia.Multicenter prospective study for clinical and endoscopic efficacies of leukocytapheresis therapy in patients with ulcerative colitis.A large-scale, prospective, observational study of leukocytapheresis for ulcerative colitis: treatment outcomes of 847 patients in clinical practice.STEROID ADDICTION IN ULCERATIVE COLITIS.Intravenous corticotrophin vs. hydrocortisone in the treatment of hospitalized patients with Crohn's disease: a randomized double-blind study and follow-up.
P2860
Q24185774-E4A7ECC5-B6DE-4310-AEB5-8E2DCFF26275Q24185876-8FB35459-C8EB-4B9C-BCD2-6B1E89C1AE2FQ24198024-99047B52-9A86-46DC-862F-49809DB977BFQ24198786-72F71B67-4F4F-407A-ADFE-0D503408276FQ24246085-FE9ED0ED-DBEB-48E2-B02F-A58E59267AF7Q24246220-2B6E6B82-0981-4858-A340-5274FCA29218Q24248026-954B37F9-CAAA-4749-9954-74C15BC61FD6Q28362796-F311AD72-BF65-42BB-BC46-54651A507F17Q33853564-34FE4DEB-034E-4DB9-875F-8A3FC6629544Q34100485-8102A9D8-7E11-425E-AACE-C26E11D61AAEQ34380050-66677676-4F43-44E1-8691-2DA482CEBC4DQ34394112-FBC0C857-9554-4A72-B268-4300B67E3B24Q34403155-EC2AF259-65E7-404E-AA75-88071F17565AQ34481604-769098A2-A18E-47AD-97EC-6ABB3901516FQ34529329-8FCB5C92-C9C7-4FF3-A2DA-EF29316C0F56Q35010974-03B98ABE-A46C-4F13-9A1E-8B96E46DADF1Q35648647-88D9A3CE-6894-4B1A-83AB-5BDE44413D29Q35745212-B75491F7-6D8D-4D9B-8EA6-65648770933BQ36582723-F7706BF4-24DA-4B7D-A266-3576432C8E60Q36705813-244043CD-6F74-443C-93C8-5622A387174AQ36788178-E0FA5AD4-3084-4D82-8AB4-8927AAB527CAQ37965684-F9B5F4D4-66A1-4D75-90CA-CF8AAE338E40Q38443024-C429B28A-C3C5-4564-961A-8D414DD87E92Q38571119-373A11CA-239D-42D0-A793-1F09EC92C1DAQ38633318-A310E709-3253-42E8-A4D8-0627DBADA7BEQ38828972-E0026098-577F-41C6-99A1-B31B8203B91AQ38938913-79CBE0AF-D9E8-4C96-8F67-CB6BD68078BDQ39252060-418A1369-83FF-4086-A74B-7D0082FEEA03Q39890648-87D4096B-80BA-45A8-BBE8-E02D8E8A92CFQ40090889-4EB1B3A0-B71F-4CDA-9ED9-FC474EA70FD5Q40131807-26412762-43D2-428A-AECB-A1ED5A31F8B1Q41650250-E5DC77BA-06AB-4407-9F8E-DC1FBA9555D7Q41948851-23263EA6-2D4B-44A0-B4C6-90399D3BE077Q42937352-2B19F094-F10C-4AB9-847E-491151F8EE93Q43096294-A5E41F5A-846A-4DF3-89A2-935E8DF9B45AQ43487343-76ED7117-77E2-4467-AA4C-4BBCB4A81242Q45770002-06399483-569F-4EA0-BF8D-7958FA5804F6Q50478862-407096B8-4600-44F2-B265-718D3492D3A8Q52284589-AFDA43B8-3C78-49F5-AD8A-729E1CE0E04CQ53351816-53223126-8AD5-4A68-A900-9791EF0082A0
P2860
description
1959 nî lūn-bûn
@nan
1959年の論文
@ja
1959年学术文章
@wuu
1959年学术文章
@zh-cn
1959年学术文章
@zh-hans
1959年学术文章
@zh-my
1959年学术文章
@zh-sg
1959年學術文章
@yue
1959年學術文章
@zh
1959年學術文章
@zh-hant
name
Cortisone and corticotrophin in ulcerative colitis.
@en
Cortisone and corticotrophin in ulcerative colitis.
@nl
type
label
Cortisone and corticotrophin in ulcerative colitis.
@en
Cortisone and corticotrophin in ulcerative colitis.
@nl
prefLabel
Cortisone and corticotrophin in ulcerative colitis.
@en
Cortisone and corticotrophin in ulcerative colitis.
@nl
P2860
P356
P1433
P1476
Cortisone and corticotrophin in ulcerative colitis.
@en
P2093
P2860
P304
P356
10.1136/BMJ.1.5119.387
P407
P577
1959-02-01T00:00:00Z